Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 26, 2017 - Issue 9
Submit an article Journal homepage
10,718
Views
117
CrossRef citations to date
0
Altmetric
Review

Investigational phosphodiesterase inhibitors in phase I and phase II clinical trials for Alzheimer’s disease

Jos PrickaertsDepartment of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The NetherlandsCorrespondence[email protected]
,
Pim R. A. HeckmanDepartment of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands;Department of Neuropsychology and Psychopharmacology, Maastricht University, Maastricht, The Netherlands
&
Arjan BloklandDepartment of Neuropsychology and Psychopharmacology, Maastricht University, Maastricht, The Netherlands
Pages 1033-1048 | Received 27 Apr 2017, Accepted 02 Aug 2017, Published online: 09 Aug 2017

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.